P143Role of NO in apelin-induced protection against myocardial ischemia and reperfusion injury

    loading  Checking for direct PDF access through Ovid

Abstract

Background

Cardioprotective activity of the adipocytokine apelin is attributed to upregulation of endothelial nitric oxide synthase (NOS). This study was designed to examine effects of a synthesized 12 C-terminal residue of apelin (A-12) and NG-nitro-L-arginine methyl ester (L-NAME), a non-selective NOS inhibitor, in ex vivo and in vivo models of ischemia/reperfusion injury.

Methods

Isolated working rat hearts were subjected to 35-min global ischemia followed by 30-min reperfusion. 140 μM A-12 and 100 μM L-NAME were administered separately or in combination before global ischemia. Metabolic state of reperfused hearts and lactate dehydrogenase (LDH) leakage in perfusate were assessed by enzymatic methods. Anaesthetized open-chest rats were subjected to 40-min regional ischemia and 60-min coronary reperfusion. L-NAME (37 μmol/kg 10 min prior to reperfusion) and A-12 (0.35 μmol/kg at the onset of reperfusion) were injected intravenously; control rats received saline. Myocardial injury was evaluated by MB-creatine kinase (MB-CK) and LDH activities in plasma. Infarct size was determined by the Evans Blue/2,3,5-triphenyl tetrazolium chloride staining method.

Results

Preischemic infusion of A-12 increased recovery of cardiac function during reperfusion compared with control and resulted in enhanced restoration of myocardial ATP, adenine nucleotide pool, phosphocreatine and reduction of myocardial lactate and lactate/pyruvate ratio. Coadministration of A-12 and L-NAME aggravated recovery of coronary flow and cardiac function compared with these indices after A-12 treatment. Cardiac dysfunction was associated with increase in LDH release in myocardial effluent, reduction of glucose oxidation and abolishment of augmented restoration of high energy phosphates. A-12 administration after regional ischemia in anesthetized rats led to a transient reduction of mean arterial blood pressure (MABP), significant limitation of infarct size expressed as a percent of area at risk (MI/AR, %) and decreased LDH and MB-CK activities in plasma at the end of reperfusion compared with control. Subsequent administration of L-NAME and A-12 resulted in less reduction of MABP and substantially increased MI/AR ratio and MB-CK and LDH activities in plasma compared to the values in the A-12 group.

Conclusions

The results demonstrate the principal role of NO as a mediator of overall cardioprotection afforded by apelin.

Related Topics

    loading  Loading Related Articles